Oncotelic Therapeutics OTLC
OTC OTLC
$0.01 +0.00 (+0.00%)
At close: Nov 6, 2026 · 4:00 PM EST

Oncotelic Therapeutics (OTLC) Purchase of Investments (2016)

Updated

Analysis

Oncotelic Therapeutics (OTLC) Purchase of Investments (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,257.26 Bn 1,230.87 Bn 20.46 Bn 258.00 Mn
2 Johnson & Johnson 679.82 Bn 599.68 Bn 17.30 Bn 919.00 Mn
3 AbbVie 519.07 Bn 487.08 Bn 13.12 Bn 300.00 Mn
4 Merck 366.57 Bn 329.51 Bn 13.19 Bn -
5 Novartis Ag 317.20 Bn 290.44 Bn - -
6 Astrazeneca 294.13 Bn 268.02 Bn 13.26 Bn -
7 Amgen 251.28 Bn 202.93 Bn 7.58 Bn -
8 Gilead Sciences 210.25 Bn 185.35 Bn 6.73 Bn 1.00 Mn
9 Pfizer 168.23 Bn 115.59 Bn 12.56 Bn 4.40 Bn
10 Oncotelic Therapeutics 7.16 Mn 6.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 2.10 Mn
Sep 30, 2016 3.31 Mn
Jun 30, 2016 2.99 Mn
Mar 31, 2016 12.61 Mn
API Access

Oncotelic Therapeutics Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=OTLC&period=max&api_key=YOUR_API_KEY